Preservation of uroplakins by 2-mercaptoethanesulfonate in cyclophosphamide-induced rat cystitis
- 26 February 2010
- journal article
- research article
- Published by Springer Nature in Archives of Toxicology
- Vol. 85 (1) , 51-57
Abstract
Cyclophosphamide (CP) causes extensive cystitis, which is ameliorated with concomitant treatment with mesna. We investigated the protective mechanisms of mesna in the expression of uroplakin (UP), a strong mucosal barrier against toxic materials, in CP-induced rat cystitis. A total of 54 SD female rats received a single intraperitoneal injection of 200 mg of CP/kg. Six CP-treated, 6 CP + mesna (120 mg/kg)-treated rats, and 6 negative controls were sequentially sacrificed at 12, 24, and 72 h post-CP injection. The bladders were harvested. The levels of UPIa, Ib, II, and III mRNA on real-time PCR, the UPII and III expressions on immunoblotting, and the UPII expression on immunolocalization study in the harvested bladder were maximally suppressed within 12–24 h, whereas partially or completely recovered at 24–72 h post-CP injection. In addition, the responses in UPs after a CP insult were heterogeneous (i.e., markedly suppressed in UPII and lesser destructive in UPIII). Even though the mesna-treated rats also showed transient and small reductions in the mRNA levels of all UPs, mesna clearly preserved the UP expressions of mRNA and protein in CP-induced urinary bladder mucosa. In conclusion, this study suggests that CP transiently reduces the expression of UPs and mesna protects the urinary bladder mucosa through the preservation of UPs protein.Keywords
This publication has 16 references indexed in Scilit:
- Expressions of Uroplakins in the Mouse Urinary Bladder with Cyclophosphamide-Induced CystitisJournal of Korean Medical Science, 2009
- Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphomaLeukemia & Lymphoma, 2008
- Detection and quantification of hepatitis B virus DNA by SYBR green real-time polymerase chain reactionEuropean Journal of Clinical Microbiology & Infectious Diseases, 2006
- A model of hemorrhagic cystitis induced with acrolein in miceBrazilian Journal of Medical and Biological Research, 2006
- Monitoring of urinary acrolein concentration in patients receiving cyclophosphamide and ifosphamideJournal of Chromatography B, 2004
- Urinary excretion and pharmacokinetics of acrolein and its parent drug cyclophosphamide in bone marrow transplant patientsBone Marrow Transplantation, 1998
- Selective Interactions of UPIa and UPIb, Two Members of the Transmembrane 4 Superfamily, with Distinct Single Transmembrane-domained Proteins in Differentiated Urothelial CellsJournal of Biological Chemistry, 1995
- A prospective randomized evaluation of three schedules of mesna administration in patients receiving an ifosfamide-containing chemotherapy regimen: sustained efficiency and simplified administrationJournal of Cancer Research and Clinical Oncology, 1995
- Pharmacokinetics of intravenous and oral sodium 2‐mercaptoethane sulphonate (mesna) in normal subjects.British Journal of Clinical Pharmacology, 1987
- Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and CyclophosphamideNew England Journal of Medicine, 1983